Zymes and Kaneka Nutrients sign an exclusive co-development and co-marketing agreement for water-soluble KANEKA QHTM (Ubiquinol) using Zymes’ PTS
November 3, 2008
Zymes and Kaneka Nutrients sign an exclusive co-development and co-marketing agreement for water-soluble KANEKA QHTM (Ubiquinol) using Zymes’ PTS.
Food and beverage companies can now use the crystal clear liquid formulations of PTS/Ubiquinol in their product portfolios.
Hasbrouck Heights, N.J., November 3, 2008 – Zymes LLC announced that it has signed an exclusive agreement with Kaneka Nutrients L.P. for the co-development and co-marketing of water-soluble KANEKA QHTM (Ubiquinol) using Zymes’ PTS. Under the terms of the agreement, Zymes and Kaneka will co-market the water-soluble liquid and powder formulations of PTS / Kaneka QH (Ubiquinol) for use in food, beverages and dietary supplements in the United States, Canada and Mexico. The agreement also provides for a non-exclusive co-marketing agreement for PTS / KANEKA Q10TM.
“Considering their technical expertise, Kaneka was the ideal partner for Zymes’ technology”, said Benjamin D. Mamola, Chief Operating Officer at Zymes.
Zymes’ water-solubilization technology, PTS, uses nanotechnology and complexation to formulate and improve solubility of water-insoluble bioactives. Zymes, founded on efforts to deliver the health benefits of CoQ10 in an aqueous form, holds worldwide exclusive rights to PTS from the National Research Council of Canada (NRC). Zymes’ PTS delivers stabilized GRAS-affirmed PTS/CoQ10 and PTS/Ubiquinol for use in liquid and powder formulations. The technology provides for reduced particle size averaging 25 nanometers, thus providing solutions for clear beverage applications. Stability and product application testing has been successful and will continue under the agreement.
Commercial manufacturing of Zymes’ PTS has commenced through one of Zymes’ manufacturing partners. Commercial scale and quality will help satisfy the demand of Kaneka QHTM and Kaneka Q10TM for food and beverage applications.
“We are thrilled to have partnered with Zymes for the delivery of water-soluble KANEKA QHTM (Ubiquinol) and KANEKA Q10TM”, said Kazuhiko Fujii, Senior Vice President of Kaneka Nutrients.
About Kaneka Corporation: Kaneka Corporation of Japan is a $4 billion producer of chemical products including PVC resins, pharmaceutical intermediates, electrical materials, food supplements, synthetic fibers and fine chemicals. Kaneka, with its headquarters in Osaka, Japan, has 30 consolidated subsidiaries in Japan and 16 subsidiaries outside Japan. For more information about Kaneka Corporation in Japan, contact: kaneka.co.jp .
KANEKA Q10TM and KANEKA QHTM are marketed by Kaneka Nutrients L.P., with manufacturing, sales and marketing operations in Pasadena, Texas. For more information about the products visit: kanekaq10.com , kanekaqh.com
About Zymes: Zymes LLC is a bioscience company that combines science, technology and nature to create products that improve the quality of life. Zymes provides innovative solutions to its partners and consumers through proprietary science and technology, enabling new products to enhance the well-being of people and the environment. Based in Hasbrouck Heights, NJ, Zymes holds substantial intellectual property including the synthesis of coenzyme Q10, pharmaceutical drug delivery systems, food and beverage formulations and stability enabling technologies. For more information contact http://www.zymes.com or email info@zymesllc.com
